NCT06015165

Brief Summary

This will be an open, prospective, parallel-group, randomized controlled trial. Patients scheduled for complex anorectal surgery under general anesthesia will be enrolled, and the perioperative analgesia mode led by anesthesiologists will be established. Compared with the perioperative analgesia mode led by surgeons, the efficacy and safety of analgesia, quality of life and satisfaction of patients will be evaluated. This study is aimed at the feasibility and efficiacy of anesthesiologist-led treatment mode in the management of moderate and severe pain in patients after complex anorectal surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
216

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Sep 2024

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 29, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

September 10, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2025

Completed
Last Updated

November 13, 2024

Status Verified

November 1, 2024

Enrollment Period

10 months

First QC Date

August 17, 2023

Last Update Submit

November 11, 2024

Conditions

Keywords

ambulatory surgeryanorectal surgerypostoperative analgesiaanesthesiologist-led care

Outcome Measures

Primary Outcomes (1)

  • the time of recovery of work and life after surgery day

    not requiring any additional medication and resuming full pre-operative work life content

    up to 21 days

Secondary Outcomes (5)

  • postoperative rest pain

    up to 21 days

  • postoperative defecation pain

    up to 21 days

  • adverse reactions

    up to 21 days

  • patients' satisfaction

    up to 21 days

  • total opioid use after surgery

    up to 21 days

Study Arms (2)

Anes Group

EXPERIMENTAL

In Anes Group, the anesthesiologist routinely works in the operating room, and will communicate with anorectal physicians through bedside visits, video telephone calls, and a hospital-wide electronic medical record system in the operating room. Anesthesiologists will evaluate the patient's pain degree and symptoms perioperatively at bedside, and will administer opioids or non-opioids at the optimal interval and standard dose until discharge. The anesthesiologist and the surgeon will jointly formulate the discharge medication plan and give the patient guidance on analgesic treatment.

Drug: Analgesia plan for Anes. GroupProcedure: Multi-modal analgesia during the surgery

Surg. group

ACTIVE COMPARATOR

According to the current perioperative management mode, patients in the surgeon-led group (Surg. group) will be given local anesthesia during the operation, and will receive routine ambulatory surgery anesthesia plan, and routine postoperative analgesia plan in the ward will be given to the patients, under the guidance of the department of pharmacy. The patients will receive rescue opioids and standardized NSAIDs until discharge.

Drug: Analgesia plan for Surg. GroupProcedure: Multi-modal analgesia during the surgery

Interventions

For Anes. Group, hydromorphone intravenous pump (PCIA) with 0.04mg/hr and 0.2mg/hr bolus controlled administration. Rescue opioids will be given as sufentanil 5μg/hr, depending on the time of the last intraoperative administration. NSAIDs such as flurbiprofen axetil or ibuprofen will be administered as a complementary treatment option.

Also known as: Anes Group
Anes Group

For Surg. Group, hydromorphone intravenous pump is set with the same analgesic formula as in Anes. Group. Routine prescriptions for rescue opioids (tramadol) and NSAIDs according to pain level recommended by the pharmacy department will be administered.

Also known as: Surg. Group
Surg. group

Multi-modal analgesia, including intraoperative long-acting local anesthetics (ropivacaine and methylene blue), perioperative narcotic analgesics, and postoperative laxative and antibiotics. PCIA with the same analgesic formula will be applied in both groups.

Also known as: Intraoperative analgesic plan
Anes GroupSurg. group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesia (ASA) grading I-III
  • ≥18 years old
  • Patients scheduled for complex anorectal surgery under general anesthesia, e.g., mixed hemorrhoidectomy/sclerosing agent injection/ligation, radical anal fistula resection, peri-anal abscess incision and drainage

You may not qualify if:

  • Informed consent not obtained
  • Allergic to general anesthetics, hydromorphone, non-steroidal anti-inflammatory drugs and other related ingredients
  • Opioid abuse or pathological pain that requires long-term analgesic treatment
  • History of severe asthma attack and acute phase of asthma
  • Moderate or above ventilatory function or diffusion dysfunction
  • Liver dysfunction reached Child B grade; Renal insufficiency reached chronic kidney disease (CKD) stage IV
  • Gastric retention and paralytic ileus
  • Pregnant and lactating patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, 100029, China

RECRUITING

Department of Anesthesiology

Beijing, Beijing Municipality, 100029, China

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Wei Xia Li, Doctor

    China-Japan Friendship Hospital

    STUDY DIRECTOR

Central Study Contacts

Li Fang WANG, Doctor

CONTACT

Meng Tao ZHENG, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open label trial.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients undergoing complex anorectal surgery under general anesthesia will be included in this study. In Anes Group, the anesthesiologist routinely works in the operating room, and will communicate with anorectal physicians through bedside visits, video telephone calls, and a hospital-wide electronic medical record system in the operating room. Anesthesiologists will administer opioids or non-opioids at the optimal interval and standard dose until discharge. The anesthesiologist and the surgeon will jointly formulate the discharge medication plan and give the patient guidance on analgesic treatment. Patients in the Surg. Group will be given local anesthesia during the operation, and will receive routine ambulatory surgery anesthesia plan, and routine postoperative analgesia plan in the ward will be given to the patients, under the guidance of the department of pharmacy. The patients will receive rescue opioids and standardized NSAIDs until discharge.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
attending doctor

Study Record Dates

First Submitted

August 17, 2023

First Posted

August 29, 2023

Study Start

September 10, 2024

Primary Completion

June 30, 2025

Study Completion

October 10, 2025

Last Updated

November 13, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations